Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Deng, Bin ^a,b   Zhu, Ji Min ^b   Wang, Yi ^b   Liu, Tao Tao ^b   Ding, Yan Bing ^a   Xiao, Wei Ming ^a   Lu, Guo Tao ^a   Bo, Ping ^c   Shen, Xi Zhong ^b  

^a YANGZHOU UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^c CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CELL HYPOXIA; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; STOMACH CANCER; TUMOR GROWTH; ADULT; AGED; ANOXIA; CANCER STAGING; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ADULT; AGED; ANOXIA; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNE TOLERANCE; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84878292368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063777     Document Type: Article

References (32)

1. Parkin DM, (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543.
2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20.
3. Whiteside TL, (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27: 5904-5912.
4. Wu H, Liang X, Fang Y, Qin X, Zhang Y, et al. (2008) Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed Pharmacother 62: 613-621.
5. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
6. Harris AL, (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
7. Wei J, Wu A, Kong LY, Wang Y, Fuller G, et al. (2011) Hypoxia potentiates glioma-mediated immunosuppression. PLoS One 6: e16195.
8. Chouaib S, Messai Y, Couve S, Escudier B, Hasmim M, et al. (2012) Hypoxia promotes tumor growth in linking angiogenesis to immune escape. Front Immunol 3: 21.
9. Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, et al. (2011) Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475: 226-230.
10. Zou W, (2006) Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews Immunology 6: 295-307.
11. Shen LS, Wang J, Shen DF, Yuan XL, Dong P, et al. (2009) CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol 131: 109-118.
12. Raghavan S, Quiding-Jarbrink M, (2011) Regulatory T cells in gastrointestinal tumors. Expert Rev Gastroenterol Hepatol 5: 489-501.
13. Muthu Raja KR, Rihova L, Zahradova L, Klincova M, Penka M, et al. (2012) Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma. PLoS One 7: e47077.
14. Wang Y, Ma Y, Fang Y, Wu S, Liu L, et al. (2012) Regulatory T cell: a protection for tumour cells. Journal of Cellular and Molecular Medicine 16: 425-436.
15. Chen W, Konkel JE, (2010) TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J Mol Cell Biol 2: 30-36.
16. Wang Y, Li Z, Zhang H, Jin H, Sun L, et al. (2010) HIF-1alpha and HIF-2alpha correlate with migration and invasion in gastric cancer. Cancer Biol Ther 10: 376-382.
17. Kim HI, Kim H, Cho HW, Kim SY, Song KJ, et al. (2011) The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer. J Surg Oncol 104: 728-733.
18. Beyer M, Schultze JL, (2006) Regulatory T cells in cancer. Blood 108: 804-811.
19. Nishikawa H, Sakaguchi S, (2010) Regulatory T cells in tumor immunity. Int J Cancer 127: 759-767.
20. Yuan XL, Chen L, Li MX, Dong P, Xue J, et al. (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134: 277-288.
21. Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A, (2003) CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98: 1089-1099.
22. Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, et al. (2008) Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer 44: 1875-1882.
23. Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, et al. (2012) Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer. Int J Clin Oncol.
24. Semenza GL, (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33: 207-214.
25. Lukashev D, Ohta A, Sitkovsky M, (2007) Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26: 273-279.
26. Ben-Shoshan J, Maysel-Auslender S, Mor A, Keren G, George J, (2008) Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38: 2412-2418.
27. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.
28. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, et al. (2008) A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9: 632-640.
29. Apostolou I, Verginis P, Kretschmer K, Polansky J, Huhn J, et al. (2008) Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol 28: 619-624.
30. Wang Y, Deng B, Tang W, Liu T, Shen X (2013) TGF-beta1 Secreted by Hepatocellular Carcinoma Induces the Expression of the Foxp3 Gene and Suppresses Antitumor Immunity in the Tumor Microenvironment. Dig Dis Sci.
31. Brahimi-Horn MC, Chiche J, Pouyssegur J, (2007) Hypoxia and cancer. J Mol Med (Berl) 85: 1301-1307.
32. Noda S, Yashiro M, Nshii T, Hirakawa K, (2010) Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer 46: 995-1005.